BioXcel Therapeutics shares pop after audit of Alzheimer’s trial data
October 25, 2023 at 08:44 AM EDT
Audit findings support application for approval of treatment for Alzheimer's-related agitation, company says
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|